Requested article is recognized. But, there is no holdings information available for it.
A notification was automatically sent to our data department to investigate. The information below was supplied.
Please check in a few days to see if it has been corrected.
Article:Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Source:Yearbook of Obstetrics, Gynecology and Women's Health, Volume 2011, Issue null, Pages 456-457